SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $421,000 | +41.8% | 13,000 | +31.3% | 0.00% | – |
Q4 2021 | $297,000 | +40.1% | 9,900 | +47.8% | 0.00% | – |
Q2 2021 | $212,000 | -79.4% | 6,700 | -82.9% | 0.00% | -100.0% |
Q1 2021 | $1,027,000 | +95.6% | 39,241 | +28.2% | 0.00% | -50.0% |
Q1 2020 | $525,000 | -70.6% | 30,600 | -59.9% | 0.00% | -60.0% |
Q4 2019 | $1,783,000 | +6.1% | 76,386 | +24.8% | 0.01% | 0.0% |
Q3 2019 | $1,681,000 | -23.9% | 61,200 | -8.3% | 0.01% | -16.7% |
Q2 2019 | $2,209,000 | -52.0% | 66,762 | -49.2% | 0.01% | -57.1% |
Q1 2019 | $4,606,000 | +34.3% | 131,461 | +24.1% | 0.01% | +40.0% |
Q4 2018 | $3,430,000 | -30.8% | 105,972 | +7.6% | 0.01% | -9.1% |
Q3 2018 | $4,959,000 | +145.0% | 98,502 | +122.9% | 0.01% | +120.0% |
Q2 2018 | $2,024,000 | 0.0% | 44,200 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $2,024,000 | -18.0% | 44,200 | -23.4% | 0.01% | -58.3% |
Q2 2017 | $2,469,000 | -6.9% | 57,700 | -32.0% | 0.01% | -14.3% |
Q1 2017 | $2,653,000 | +137.7% | 84,900 | +92.1% | 0.01% | +180.0% |
Q4 2016 | $1,116,000 | -14.3% | 44,200 | -16.4% | 0.01% | -16.7% |
Q3 2016 | $1,302,000 | -6.0% | 52,872 | -24.2% | 0.01% | -25.0% |
Q2 2016 | $1,385,000 | – | 69,783 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |